Search

Search bills, members, committees and pages...

Sign In

ASSOCIATION FOR ACCESSIBLE MEDICINES

PreviousNext

53 federal lobbying filings, 2023 to 2026.

ASSOCIATION FOR ACCESSIBLE MEDICINES is a client on 53 federal lobbying filings, 2023 to 2026, reporting $1.6M across them. Trade association representing the US generic drug industry. Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

7 it has hired, by filings.

RegistrantFilingsReported
ASSOCIATION FOR ACCESSIBLE MEDICINES15—
THE GIBSON GROUP, LLC14$510K
FOLEY & LARDNER LLP7$400K
SQUIRE PATTON BOGGS7$170K
RUBIN, TURNBULL & ASSOCIATES4$350K
FEROX STRATEGIES3$90K
TWINLOGIC STRATEGIES, LLP3$70K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202616$780K$1.7M
202520$570K$3.1M
20249$120K$3M
20238$120K$2M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
TRDTrade (domestic/foreign)42
CPTCopyright/Patent/Trademark34
PHAPharmacy29
HCRHealth Issues21
MMMMedicare/Medicaid15
LBRLabor Issues/Antitrust/Workplace14
BUDBudget/Appropriations10
MANManufacturing7

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 1041Affordable Prescriptions for Patients Act14
S. 1096Preserve Access to Affordable Generics and Biosimilars Act11
S. 1040Drug Competition Enhancement Act10
S. 43Skinny Labels, Big Savings Act6
H.R. 1051To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug applic…5
H.R. 1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.5
H.R. 3152Patent Eligibility Restoration Act of 20255
H.R. 3160PREVAIL Act5
H.R. 3269ETHIC Act5
S. 1302Increasing Transparency in Generic Drug Applications Act5
S. 1414Expedited Access to Biosimilars Act5
S. 1546Patent Eligibility Restoration Act of 20255
S. 1553PREVAIL Act5
S. 1954Biosimilar Red Tape Elimination Act5
H.R. 1396PILLS Act4
H.R. 4132Prescription Information Modernization Act of 20254
H.R. 5526Biosimilar Red Tape Elimination Act4
S. 2027Prescription Information Modernization Act of 20254
S. 2276ETHIC Act4
H.R. 3955RAPID Reserve Act3
H.R. 5811Restoring America’s Leadership in Innovation Act of 20253
H.R. 6485Skinny Labels, Big Savings Act3
S. 1097Interagency Patent Coordination and Improvement Act of 20253
S. 1784MAPS Act3
S. 1891PILLS Act3

Lobbyists

Named on the filings.

LobbyistClientsFilings
KARIN HESSLER115
PETER KELBEL115
JOSEPH GIBSON114
ILHAAM JAFFER113
CRAIG BURTON111
KATHERINE RAAB110
JOHN MURPHY17
JOHN STROM17
KATIE SCHOETTLER16
EVERETT EISSENSTAT15
HEATHER TURNBULL14
KARA-MARIE URBAN14
MARK RATNER14
MICHAEL BURLEY14
WILLIAM RUBIN14
DEBRA DIXON13
GREG BARNES13
JARED RIFIS13
MARK WILLIAMS13
MICHAEL TAGGART13
ZACHARY FRIEND13
ALEX KEETON12
CRISTINA ANTELO12
JOHN MASON LONG12
KATELYN SCHULTZ12

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ASSOCIATION FOR ACCESSIBLE MEDICINESASSOCIATION FOR ACCESSIBLE MEDICINES2026 second_quarter$870KJul 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 second_quarter$50KJul 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFOLEY & LARDNER LLP2026 second_quarter$80KJul 19, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESRUBIN, TURNBULL & ASSOCIATES2026 second_quarter$150KJul 19, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTWINLOGIC STRATEGIES, LLP2026 second_quarter$40KJul 17, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESSQUIRE PATTON BOGGS2026 second_quarter—Jul 16, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTHE GIBSON GROUP, LLC2026 second_quarter$70KJul 10, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTWINLOGIC STRATEGIES, LLP2026 first_quarter$30KApr 21, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESASSOCIATION FOR ACCESSIBLE MEDICINES2026 first_quarter$840KApr 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFOLEY & LARDNER LLP2026 first_quarter$80KApr 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 first_quarter$40KApr 17, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESRUBIN, TURNBULL & ASSOCIATES2026 first_quarter$150KApr 17, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESSQUIRE PATTON BOGGS2026 first_quarter$30KApr 14, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTHE GIBSON GROUP, LLC2026 first_quarter$60KApr 9, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFEROX STRATEGIES2026 first_quarter—Mar 27, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTWINLOGIC STRATEGIES, LLP2026 first_quarter—Mar 12, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESRUBIN, TURNBULL & ASSOCIATES2025 fourth_quarter$50KJan 23, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESASSOCIATION FOR ACCESSIBLE MEDICINES2025 fourth_quarter$1.2MJan 20, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESFOLEY & LARDNER LLP2025 fourth_quarter$80KJan 19, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESTHE GIBSON GROUP, LLC2025 fourth_quarter$50KJan 16, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESSQUIRE PATTON BOGGS2025 fourth_quarter$50KJan 14, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESRUBIN, TURNBULL & ASSOCIATES2025 fourth_quarter—Jan 13, 2026
ASSOCIATION FOR ACCESSIBLE MEDICINESASSOCIATION FOR ACCESSIBLE MEDICINES2025 third_quarter$640KOct 20, 2025
ASSOCIATION FOR ACCESSIBLE MEDICINESFOLEY & LARDNER LLP2025 third_quarter$60KOct 18, 2025
ASSOCIATION FOR ACCESSIBLE MEDICINESSQUIRE PATTON BOGGS2025 third_quarter—Oct 14, 2025